Genocea Biosciences
GNCA
#10722
Rank
โ‚ฌ0 M
Marketcap
0,00008699ย โ‚ฌ
Share price
-85.71%
Change (1 day)
N/A
Change (1 year)

EPS for Genocea Biosciences (GNCA)

EPS in 2022 (TTM): -0,46ย โ‚ฌ

According to Genocea Biosciences 's latest financial reports the company's current EPS (TTM) is -0,45ย โ‚ฌ. In 2021 the company made an earnings per share (EPS) of -0,42ย โ‚ฌ an increase over its 2020 EPS that were of -1,01ย โ‚ฌ.

EPS history for Genocea Biosciences from 2014 to 2022

Annual EPS

Year EPS Change
2022 (TTM)-0,46ย โ‚ฌ10.23%
2021-0,42ย โ‚ฌ-58.62%
2020-1,01ย โ‚ฌ-48.21%
2019-1,95ย โ‚ฌ
2017-13,78ย โ‚ฌ13.14%
2016-12,18ย โ‚ฌ-3.31%
2015-12,60ย โ‚ฌ-23.31%
2014-16,42ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
1,18ย โ‚ฌ-361.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
6,36ย โ‚ฌ-1,505.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
1,84ย โ‚ฌ-507.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
-2,71ย โ‚ฌ 498.08%๐Ÿ‡บ๐Ÿ‡ธ USA
iBio
IBIO
-1,34ย โ‚ฌ 196.15%๐Ÿ‡บ๐Ÿ‡ธ USA